Next-generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma

Said El Shamieh 1Fatima Saleh 1Mirna A Fawaz 1Gérard Siest 1Fadi S Farhat 1Sophie Visvikis-Siest 1

PMID: 28763293

DOI: 10.1515/cclm-2017-0208

No abstract available

Keywords: endometrial carcinoma; immunohistochemistry; next-generation sequencing; personalized therapy.